ES2180783T3 - Composiciones farmaceuticas para el tratamiento de la adiccion al alcohol. - Google Patents

Composiciones farmaceuticas para el tratamiento de la adiccion al alcohol.

Info

Publication number
ES2180783T3
ES2180783T3 ES96919706T ES96919706T ES2180783T3 ES 2180783 T3 ES2180783 T3 ES 2180783T3 ES 96919706 T ES96919706 T ES 96919706T ES 96919706 T ES96919706 T ES 96919706T ES 2180783 T3 ES2180783 T3 ES 2180783T3
Authority
ES
Spain
Prior art keywords
addiction
alcohol
treatment
pharmaceutical compositions
lipofilo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96919706T
Other languages
English (en)
Inventor
Paolo Morazzoni
Ezio Bombardelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena SpA filed Critical Indena SpA
Application granted granted Critical
Publication of ES2180783T3 publication Critical patent/ES2180783T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Addiction (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION TRATA DE COMPOSICIONES FARMACEUTICAS PARA EL TRATAMIENTO DE LA ADICCION AL ALCOHOL, QUE SE CARACTERIZAN PORQUE CONTIENEN, COMO PRINCIPIO ACTIVO, UN EXTRACTO LIPOFILO PURIFICADO DE SALVIA MILTIORRHYZA BUNGE.
ES96919706T 1995-05-12 1996-05-08 Composiciones farmaceuticas para el tratamiento de la adiccion al alcohol. Expired - Lifetime ES2180783T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI950958A IT1274481B (it) 1995-05-12 1995-05-12 Composizioni farmaceutiche per il trattamento della alcol-dipendenza

Publications (1)

Publication Number Publication Date
ES2180783T3 true ES2180783T3 (es) 2003-02-16

Family

ID=11371582

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96919706T Expired - Lifetime ES2180783T3 (es) 1995-05-12 1996-05-08 Composiciones farmaceuticas para el tratamiento de la adiccion al alcohol.

Country Status (16)

Country Link
US (1) US5904923A (es)
EP (1) EP0824356B1 (es)
JP (1) JP2955370B2 (es)
KR (1) KR100290029B1 (es)
CN (1) CN1066336C (es)
AT (1) ATE221384T1 (es)
AU (1) AU695010B2 (es)
CA (1) CA2220703C (es)
DE (1) DE69622704T2 (es)
DK (1) DK0824356T3 (es)
ES (1) ES2180783T3 (es)
IT (1) IT1274481B (es)
NO (1) NO318659B1 (es)
PT (1) PT824356E (es)
RU (1) RU2153345C2 (es)
WO (1) WO1996035441A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ298532B6 (cs) 1997-07-30 2007-10-31 Indena S. P. A. Sójový extrakt, zpusob jeho prípravy a farmaceutický prostredek, který jej obsahuje
US5968746A (en) 1997-11-26 1999-10-19 Schneider; David R. Method and apparatus for preserving human saliva for testing
AU2001286409A1 (en) * 2000-08-03 2002-02-18 Hong Kong University Of Science And Technology N-methyl-d-aspartate receptor antagonists
CN1304723A (zh) * 2001-01-16 2001-07-25 中山大学 含二氢呋喃环结构的丹参酮类化合物用于治疗肝性脑病的药物
US6852342B2 (en) * 2002-03-26 2005-02-08 Avoca, Inc. Compounds for altering food intake in humans
WO2004058245A1 (fr) * 2002-12-31 2004-07-15 Zhongshan Univertsity Utilisation de la tanshinone iia dans la prophylaxie ou le traitement de l'atherosclerose
US9827314B2 (en) * 2003-12-08 2017-11-28 Mars, Incorporated Edible compositions which are adapted for use by a companion animal
JP2008538748A (ja) * 2005-04-07 2008-11-06 ハイシアム， インコーポレイテッド 不安、物質乱用及び依存の予防のための改良型方法及び組成物
GB201312205D0 (en) * 2013-07-08 2013-08-21 Univ Leuven Kath Anticonvulsant activity of dan shen extracting compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1239281B (it) * 1989-10-27 1993-10-19 Indena Spa Composizioni per la riduzione dei depositi di grasso superfluo a base di principi attivi di origine vegetale ad attivita' agonista dell'adenilato ciclasi o/e ad attivita' antifosfodiesterasica
RU2011382C1 (ru) * 1989-11-20 1994-04-30 Научно-исследовательский институт фармакологии Томского научного центра РАН Антиалкогольное средство
US5204369A (en) * 1991-07-01 1993-04-20 The Endowment For Research In Human Biology Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse

Also Published As

Publication number Publication date
DE69622704T2 (de) 2003-04-03
HK1009096A1 (en) 1999-05-28
CN1066336C (zh) 2001-05-30
JP2955370B2 (ja) 1999-10-04
WO1996035441A1 (en) 1996-11-14
DK0824356T3 (da) 2002-11-25
NO975177D0 (no) 1997-11-11
AU695010B2 (en) 1998-08-06
AU5815396A (en) 1996-11-29
PT824356E (pt) 2002-12-31
CN1184429A (zh) 1998-06-10
CA2220703A1 (en) 1996-11-14
CA2220703C (en) 2001-07-24
ITMI950958A1 (it) 1996-11-12
KR19990014692A (ko) 1999-02-25
EP0824356B1 (en) 2002-07-31
IT1274481B (it) 1997-07-17
RU2153345C2 (ru) 2000-07-27
KR100290029B1 (ko) 2001-05-15
NO318659B1 (no) 2005-04-25
EP0824356A1 (en) 1998-02-25
US5904923A (en) 1999-05-18
ATE221384T1 (de) 2002-08-15
JPH10512583A (ja) 1998-12-02
NO975177L (no) 1997-11-11
DE69622704D1 (de) 2002-09-05
ITMI950958A0 (it) 1995-05-12

Similar Documents

Publication Publication Date Title
ES2194501T3 (es) Derivados de amidinas, su preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
HN1999000124A (es) Derivados de pirazol substituido.
GT199900203A (es) Composiciones de celecoxib.
ES2171533T3 (es) Composiciones que contienen nebivolol micronizado.
BRPI0418031A (pt) inibidores de quinase fosfonato-substituìdos
CR6726A (es) Compuestos azapoliciclicos condensados con arilo
PA8442001A1 (es) Derivados de pirimidina biciclica condensada
ES2169147T3 (es) Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento.
ES2156603T3 (es) Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.
ES2187675T3 (es) (metilsulfonil)fenil-2-(5h)-furanonas como inhibidores de cox-2.
HN2000000137A (es) Pirimidina-2,4,6-trionas inhibidores de metaloproteinasas
PA8479201A1 (es) Derivados del acido hidroxi-pipecolato hidroxamico
HN2001000224A (es) Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos.
PA8493701A1 (es) Compuestos para tratar la obesidad
BRPI0409680A (pt) análogos de fosfonato anti-cáncer
GT199800101A (es) Composicion farmaceutica solida que contiene un derivado de benzofurano.
AR013001A1 (es) Derivados de la piperazina, procedimientos para prepararlos, las composiciones farmaceuticas que los contienen, su utilizacion como medicamentoy el metodo para tratar enfermedades mediadas por la taquinina.
ES2181130T3 (es) Antagonistas quinazolin-4-ona del ampa.
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
ECSP045353A (es) Derivados de benzoxazinona, su preparación y aplicación como medicamentos
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
GT200000001A (es) Derivados de eter propargilico novedosos.
ES2180783T3 (es) Composiciones farmaceuticas para el tratamiento de la adiccion al alcohol.
GT199900081A (es) Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos.
HN2000000045A (es) Nuevas combinaciones farmaceuticas para inhibidores de la nos.